Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bambermycin
2. Flavomycin
3. Flavomycins
4. Flavophospholipol
5. Flavophospholipols
6. Menomycin
7. Moenomycins
1. Flavofosfolipol
2. Gainpro
3. Menomycin
4. Bambermycine [inn-french]
5. Bambermycinum [inn-latin]
6. Bambermicina [inn-spanish]
7. Bambermycin [inn]
8. Einecs 234-246-7
9. Unii-pp922a42v2
10. Pp922a42v2
11. Db11377
12. Ncgc00181293-01
13. Antibiotic Complex, Containing Mainly Moenomycin A And C, Obtained From Cultures Of Streptomyces Bambergiensis, Or The Same Substance Obtained By Any Other Means
14. Antibiotic Complex, Containing Mainly Moenomycin A And C, Obtained From Cultures Of Streptomyces Bambergiensis, Or The Same Substance Obtained By Any Other Means. Bambermycin
| Molecular Weight | 1597.6 g/mol |
|---|---|
| Molecular Formula | C70H109N4O35P |
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 18 |
| Hydrogen Bond Acceptor Count | 35 |
| Rotatable Bond Count | 39 |
| Exact Mass | 1596.6609982 g/mol |
| Monoisotopic Mass | 1596.6609982 g/mol |
| Topological Polar Surface Area | 602 Ų |
| Heavy Atom Count | 110 |
| Formal Charge | 0 |
| Complexity | 3390 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 26 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 3 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Direct Compression
Fillers, Diluents & Binders
Chewable & Orodispersible Aids
Taste Masking
Co-Processed Excipients
ABOUT THIS PAGE
A Flavofosfolipol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flavofosfolipol, including repackagers and relabelers. The FDA regulates Flavofosfolipol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flavofosfolipol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Flavofosfolipol supplier is an individual or a company that provides Flavofosfolipol active pharmaceutical ingredient (API) or Flavofosfolipol finished formulations upon request. The Flavofosfolipol suppliers may include Flavofosfolipol API manufacturers, exporters, distributors and traders.
Flavofosfolipol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flavofosfolipol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flavofosfolipol GMP manufacturer or Flavofosfolipol GMP API supplier for your needs.
A Flavofosfolipol CoA (Certificate of Analysis) is a formal document that attests to Flavofosfolipol's compliance with Flavofosfolipol specifications and serves as a tool for batch-level quality control.
Flavofosfolipol CoA mostly includes findings from lab analyses of a specific batch. For each Flavofosfolipol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flavofosfolipol may be tested according to a variety of international standards, such as European Pharmacopoeia (Flavofosfolipol EP), Flavofosfolipol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flavofosfolipol USP).
LOOKING FOR A SUPPLIER?
